Molecule intelOpportunity: ModerateEssentialCrowded market

Permethrin

137 brands · 70 companies · product forms

ATC: P03AC04

Opportunity snapshot

Launch attractiveness
36
Market saturation
97
Price room
100
Regulatory risk
0
137
brands
70
companies
Rs 138.06
median price
130
price points
12.04x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 53.85
MedianRs 138.06
Most expensiveRs 648.52
Spread12.04×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 12.04x across 130 trusted points (Rs 53.85-648.52). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Permethrin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(3) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

70 canonical companies and 137 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 12.04x across 130 trusted points (Rs 53.85-648.52). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.